Design and verification of the screening questionnaire for benign paroxysmal positional vertigo
10.3760/cma.j.cn15330-20210716-00462
- VernacularTitle:良性阵发性位置性眩晕筛查问卷的设计与验证
- Author:
Qi QIAO
1
;
Ganggang CHEN
;
Chunming ZHANG
;
Liyuan ZHOU
;
Ying LI
;
Hui HUANGFU
Author Information
1. 山西医科大学护理学院，太原030001
- Keywords:
Benign paroxysmal positional vertigo;
Questionnaire;
Screening
- From:
Chinese Journal of Otorhinolaryngology Head and Neck Surgery
2022;57(6):677-682
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To design and validate a high-quality rapid screening questionnaire based on the common medical history and clinical experience of benign paroxysmal positional vertigo (BPPV).Methods:A questionnaire was designed based on expert′s opinions, and the first-time patients who complained of dizziness and vertigo in the vertigo clinic of the First Hospital of Shanxi Medical University from September 2020 to June 2021 were prospectively screened. Taking the displacement test as the gold standard, the reliability and validity of the questionnaire were tested to evaluate its authenticity, reliability and benefit value. This study was divided into three steps. The first step was to conduct a pre-experiment and to adjust the questionnaire items; the second step was to determine the questionnaire items and the best cut-off value; the third step was to screen patients with the best cut-off value and to evaluate the quality of the questionnaire.Results:Seven items were finalized. The Cronbach′s coefficient of the questionnaire was 0.675, the content validity was 0.85, the KMO value of the construct validity was 0.648, and there were 4 factors with characteristic root>1, and the cumulative contribution rate was 76.309%. The area under the receiver operating characteristic curve (ROC) was 0.938, and its optimal cut-off value was 4.5 points. At this point, the sensitivity was 88.89% and the specificity was 85.44%.Conclusion:The BPPV rapid screening questionnaire has high sensitivity and specificity, which can be used for clinical screening of BPPV patients.
